Role of prohibitin in intestinal inflammation
抑制素在肠道炎症中的作用
基本信息
- 批准号:7154371
- 负责人:
- 金额:$ 4.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:biological signal transductioncell linecolitisdisease /disorder modelgastrointestinal epitheliumgene expressiongene targetingimmunoregulationinflammationinflammatory bowel diseasesinterleukin 6laboratory mouseoxidative stresspostdoctoral investigatorprotein structure functiontranscription factorwound healing
项目摘要
DESCRIPTION (provided by applicant): Prohibitin (PHB) is implicated to be involved in diverse cellular processes such as oxidative stress. The expression and function of PHB in the normal intestine and during intestinal inflammation are not known. Oxidative stress plays an important role in the pathogenesis of inflammatory bowel diseases due to its effects on mucosal barrier disruption and inflammation. Given the potential role of PHB in regulating oxidative stress during various physiological conditions, PHB may be involved in modulating oxidative stress associated with intestinal inflammation. The overall goal of this proposal is to characterize the regulation of PHB in intestinal epithelial cells and its role in modulating inflammation-induced oxidative stress and wound healing. The regulation of PHB expression by the immunoregulatory cytokine IL-6 will be studied. The role of PHB in oxidative stress and wound healing will be determined using an intestinal epithelial cell line over- or under-expressing PHB. Also, the in vivo effect of IL-6 knockout on PHB expression and wound healing will be assessed during experimental colitis. Thus, studies on PHB will lead to a better understanding of inflammation-induced oxidative stress and may lead to novel therapies for intestinal inflammatory disorders.
描述(由申请人提供):Prohibitin(PHB)涉及多种细胞过程,如氧化应激。在正常肠道和肠道炎症过程中,PHB的表达和功能尚不清楚。氧化应激通过影响黏膜屏障的破坏和炎症反应,在炎症性肠病的发病机制中起重要作用。考虑到在各种生理条件下PHB在调节氧化应激中的潜在作用,PHB可能参与调节与肠道炎症相关的氧化应激。该提案的总体目标是表征肠道上皮细胞中的PHB的调节及其在调节炎症诱导的氧化应激和伤口愈合中的作用。将研究免疫调节细胞因子IL-6对PHB表达的调节。将使用过表达或低表达PHB的肠上皮细胞系来确定PHB在氧化应激和伤口愈合中的作用。此外,将在实验性结肠炎期间评估IL-6敲除对PHB表达和伤口愈合的体内作用。因此,对PHB的研究将导致更好地理解炎症诱导的氧化应激,并可能导致肠道炎症性疾病的新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARIANNE L THEISS其他文献
ARIANNE L THEISS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARIANNE L THEISS', 18)}}的其他基金
Adipose Tissue Extracellular Vesicles in Colorectal Tumorigenesis
脂肪组织细胞外囊泡在结直肠肿瘤发生中的作用
- 批准号:
10655305 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Adipose Tissue Extracellular Vesicles in Colorectal Tumorigenesis
脂肪组织细胞外囊泡在结直肠肿瘤发生中的作用
- 批准号:
10367993 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Mitochondrial Dysfunction and Mitophagy in Ileitis
回肠炎中的线粒体功能障碍和线粒体自噬
- 批准号:
9982322 - 财政年份:2019
- 资助金额:
$ 4.6万 - 项目类别:
Diversity Supplement to R01 Mitochondrial Dysfunction and Mitophagy in Ileitis
R01 回肠炎线粒体功能障碍和线粒体自噬的多样性补充
- 批准号:
10443329 - 财政年份:2019
- 资助金额:
$ 4.6万 - 项目类别:
Mitochondrial Dysfunction and Mitophagy in Ileitis
回肠炎中的线粒体功能障碍和线粒体自噬
- 批准号:
10557967 - 财政年份:2019
- 资助金额:
$ 4.6万 - 项目类别:
Mitochondrial Dysfunction and Mitophagy in Ileitis
回肠炎中的线粒体功能障碍和线粒体自噬
- 批准号:
10450818 - 财政年份:2019
- 资助金额:
$ 4.6万 - 项目类别:
Mitochondrial Dysfunction and Mitophagy in Ileitis
回肠炎中的线粒体功能障碍和线粒体自噬
- 批准号:
10219235 - 财政年份:2019
- 资助金额:
$ 4.6万 - 项目类别:
Maintenance of intestinal epithelial cell homeostasis by prohibitin
抑制素维持肠上皮细胞稳态
- 批准号:
8737248 - 财政年份:2013
- 资助金额:
$ 4.6万 - 项目类别:
Maintenance of intestinal epithelial cell homeostasis by prohibitin
抑制素维持肠上皮细胞稳态
- 批准号:
8633115 - 财政年份:2013
- 资助金额:
$ 4.6万 - 项目类别:
Role and function of prohibitin in intestinal inflammation
抑制素在肠道炎症中的作用和功能
- 批准号:
8222138 - 财政年份:2010
- 资助金额:
$ 4.6万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:
Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 4.6万 - 项目类别:














{{item.name}}会员




